Skip to content

Randomized Controlled Trial Protocol of Electroacupuncture for Patients with Obesity Comorbid with Mild to Moderate Depression

Randomized Controlled Trial Protocol of Electroacupuncture for Patients with Obesity Comorbid with Mild to Moderate Depression (1)

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2026000533
Enrollment
Unknown
Registered
2026-03-13
Start date
2026-04-01
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity Comorbid with Mild to Moderate Depression

Interventions

Electroacupuncture Group:Electroacupuncture
Sham acupuncture group:sham acupuncture

Sponsors

Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1.Age 18-70 years (inclusive), regardless of gender; 2.Meet Western diagnostic criteria for obesity; 3.Meet ICD-10 diagnostic criteria for mild to moderate depression; 4.Hamilton Depression Scale-17 (HAMD-17) score =8 but <24; 5.Consistent obesity and antidepressant medication regimens (in terms of dosage and type) and psychotherapy regimens for 4 weeks prior to enrollment; 6.No acupuncture or herbal treatment received within 2 weeks prior to enrollment; 7.No severe cognitive or psychiatric impairment, able to understand and complete scale assessments; 8.Patient agrees to participate, voluntarily signs informed consent, and commits to all study visits, examinations, and treatments per protocol.

Exclusion criteria

Exclusion criteria: 1.Depression suspected to be caused by other factors (e.g., medications, pregnancy) based on medical history or lab tests; 2.Secondary obesity due to endocrine, genetic, central nervous system disorders, or medications; 3.History of other psychiatric disorders; 4.Weight change >5 kg within 3 months; 5.History of organic brain injury or severe head trauma; 6.Prone to infection or bleeding; 7.Severe cardiac, hepatic, renal insufficiency, metabolic disorders, or other serious systemic diseases; 8.Severe needle phobia; 9.Participation in other clinical trials within 3 months; 10.Severe suicidal tendencies; 11.Pregnant or lactating women, or women of childbearing potential refusing contraception during the study; 12.Implanted pacemakers/defibrillators, electronic devices, or metal implants potentially affected by electrical currents; 13.Inability to adhere to lifestyle interventions; 14.Other conditions deemed unsuitable by investigators.

Design outcomes

Primary

MeasureTime frame
Hamilton Depression Rating Scale;

Secondary

MeasureTime frame
Montgomery–Åsberg Depression Rating Scale;Beck Depression Inventory;Clinical Global Impressions Scale (CGI);WHO Quality of Life Brief Version;blood pressure;Body Mass Index (BMI);waist;hip circumference;Waist-Hip Ratio;Body fat percentage;blood lipids;Fasting Blood Glucose;Insulin Resistance Index;Serum inflammatory factors;cortisol;

Countries

China

Contacts

Public ContactLingying Huang

Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine

hly320@126.com13764587034

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Apr 4, 2026